Intracisternal injection of blood in the rat pro duces an angiographically demonstrable biphasic cere bral arterial vasospasm. Systemic 6-hydroxydopamine (6-0HDA) treatment in the neonatal stage, which causes a depletion of noradrenaline (NA) from both sympathetic and central NA-containing nerve fibers, prevents the de velopment of the late spasm phase, while the acute spasm occurs to the same extent as in normal animals. The oc currence of acute spasm can be prevented by lesioning in the mesencephalon of the ascending catecholamine fibers
Summary: Intracisternal injection of blood in the rat pro duces an angiographically demonstrable biphasic cere bral arterial vasospasm. Systemic 6-hydroxydopamine (6-0HDA) treatment in the neonatal stage, which causes a depletion of noradrenaline (NA) from both sympathetic and central NA-containing nerve fibers, prevents the de velopment of the late spasm phase, while the acute spasm occurs to the same extent as in normal animals. The oc currence of acute spasm can be prevented by lesioning in the mesencephalon of the ascending catecholamine fibers
In the investigation of the basic mechanism be hind cerebral arterial vasospasm, we have devel oped a subarachnoid hemorrhage (SAH) model in the rat that has shown that there is an angiograph ically demonstrable biphasic vasospasm with a maximal acute spasm at 10 min and a maximal late spasm at 2 days post SAH (Delgado et aI., 1985) . By producing selective chemical lesions with 6-hy droxydopamine (6-0HDA) in the brainstem of the adult rat prior to the SAH, we found that the cate cholamine nuclei Al and A2 [nomenclature ac cording to Dahlstrom and Fuxe (1964) ] in the me dulla oblongata via their projections to the hypo thalamus, including the median eminence, are involved in the development of spasm (Svendgaard et aI., 1985b (Svendgaard et aI., , 1986 . These findings suggest that blood does not produce vasospasm via a direct vas cular effect, but via a neural or neurohumoral mechanism.
originating in the lower brainstem and projecting to the hypothalamus, It is suggested that 6-0HDA treatment re sults in the altered spasm pattern via its effect on cate cholamine fibers projecting between the medullary Al and A2 nuclei and the hypothalamus. The occurrence of acute but not late spasm indicates that there is a different pathway underlying the two spasm phases, Key Words: Angiography-Central catecholamines-Cerebral vaso spasm-NeonataI 6-hydroxydopamine treatment-Rat.
Systemic injection of 6-0HDA in the neonatal stage causes a decrease in the catecholamine inner vation of the forebrain including the hypothalamus and an increase in the preexisting internuclear cate cholamine connections in the pons-medulla oblon gata (Sachs and Jonsson, 1973; Schmidt and Bhat nagar, 1979; Levitt and Moore, 1980) . In addition, Versteeg et aI. (1977) found a differentiated effect of neonatal 6-0HDA treatment within the hypothal amus with a decrease in the noradrenaline (NA) content of the median eminence and peri ventricular and arcuate nuclei, but no change in the paraven tricular and supraoptic cell groups. In the present study, we investigate if this differentiated effect of the innervation in the hypothalamus influences the development of spasm.
MATERIALS AND METHODS
Male Sprague-Dawley rats (SPF Strain; M\<illegaards Avlslaboratorium, Kpge, Denmark) were injected sys temically with 6-0HDA in the neonatal stage. The exper imental procedures were carried out when the animals were � 3 months old and had reached a weight of � 250 g,
Anesthesia and surgical procedures
The surgical and angiographical procedures have been described in detail in an earlier communication (Delgado et aI., 1985) and will be presented only briefly in the present study.
After initiation of the anesthesia with 4% halothane, the animals were intubated and artificially ventilated. For the surgical procedures, anesthesia was maintained with 0.75% halothane in a 70% nitrous oxide and 30% oxygen mixture. A catheter was inserted into the axillary artery bilaterally for subsequent angiography after infiltrating the skin with lidocaine hydrochloride (Xylocaine; Astra). The femoral artery and vein were cannulated for contin uous blood pressure monitoring and for infusion of drugs. Heparin (Vitrum; 75 IV/kg) was given intravenously. After surgery, the halothane was switched off and suxa methonium chloride (Celocurin, Vitrum; 3 mg/kg i.v.) was given. Thirty minutes was allowed to pass before the angiography.
Angiography
Vertebrobasilar angiography was performed via bilat eral axillary catheters using metrizamide (Amipaque; Nyegaard and Co., Oslo, Norway) as the contrast me dium. The control angiography was followed by the in jection of 0.3 ml of homologous blood intracisternally via a previously implanted catheter (Delgado et aI., 1985) . Repeat angiography was performed 10 min and 2 days after the blood injection.
After the angiography on day 0, the catheters were re moved. The animals were extubated when awake and re turned to their cages. On day 2, the animals were anes thetized and intubated as described, and catheters were reinserted into the axillary arteries for angiography.
Measurements of the vertebral and basilar arteries were made using a technique similar to that described by Gabrielsen and Greitz (1970) . The diameters were mea sured with an accuracy of 0.05 mm, which is �5% of the mean vessel diameter, using a calibrated precision lens with fixed magnification and lens-to-film distance. The values from four preselected points within the vertebro basilar system were averaged and expressed as per centage of control values. Each animal served as its own control.
Lesions
Systemic 6-0HDA in newborn animals. 6-0HDA (100 mg/kg dissolved in a 0.9% sodium chloride solution con taining ascorbic acid 0.1 mg/m!) was given subcutane ously on days 0, I, and 2 after birth. In sham-Iesioned animals, only the solvent was injected.
Bilateral lesions of ascending catecholamine pathways in mesencephalon in neonatally 6-0HDA-treated an imals. The ascending catecholamine pathways from the medulla oblongata and pons were lesioned with 6-0HDA (8 fLg in 4 fLl saline) injected in the caudal mesencephalon rostral to the locus ceruleus and the subceruleus. The fol lowing coordinates were used: 0.5 mm anterior to the in teraural line, 1.1 mm lateral to the midline, and 6.5 mm below the dura. The toothbar was kept at zero. The in jection time was 3 min followed by another 3 min before withdrawal of the cannula.
Control of lesions. The animals treated with 6-0HDA neonatally were controlled by examining the irides with fluorescence microscopy. Only animals without visible sympathetic nerve terminals in the irides were included in the study.
In addition, the NA content in the frontal lobes, hypo- 1987 thalamus, and pons-medulla oblongata was measured in all the animals (Eriksson and Persson, 1982) . In a sepa rate group of animals treated neonatally with 6-0HDA, 300-fLm coronal sections of the hypothalamic area were made. The para ventricular and the supraoptic nuclei were punched out according to the technique described by Palkovits et al. (1974) for the measurement of the NA content.
Experimental design
All the animals had control angiography followed by cisternal injection of blood. Repeat angiography was made 10 min and 2 days post SAH. Group I: eight an imals treated with 6-0HDA subcutaneously during the neonatal stage; Group II: four animals treated with the solvent subcutaneously during the neonatal stage; Group III: four animals treated with 6-0HDA neonatally, with subsequent lesioning of the ascending catecholamine pathways in the mesencephalon 2 weeks prior to the SAH; Group IV: six normal animals not subjected to 6-OHDA treatment [presented in a previous communica tion (Svendgaard et aI., 1985b) ].
Statistics
The data were analyzed using the Student t test.
RESULTS
The physiological parameters in the experimental groups are shown in Table I . The pH values were close to 7.4. The Pao2 was �140 and the Paco2 �36 mm Hg. The temperature was kept close to 37°C. The pre and post SAH MABP and pulse rate were similar in all experimental groups, with the excep tion of the neonatally 6-0HDA-treated animals that had an additional lesion of the catecholamine pathways in the mesencephalon. Cisternal blood in jection in these animals produced a marked in crease in MABP and bradycardia. To maintain the blood pressure within the autoregulated range ( < 150 mm Hg) (Hernandez et aI., 1978) , controlled hemorrhage was used. All these animals required the use of controlled hemorrhage. The amount of extracted blood ranged between 2 and 5 m!.
Intracisternal blood injection in animals injected with the solvent neonatally produced a maximal acute spasm of � 32% and a maximal late spasm of �22% (Fig. I) . The normal animals developed a similar degree of spasm. In the animals treated with 6-0HDA neonatally, there was an acute spasm at 10 min that did not differ significantly from that seen in solvent-injected animals post SAH. How ever, there was no spasm at 2 days post SAH (Figs.  1 and 2) . In the neonatally 6-0HDA-treated an imals, the subsequent lesioning of the ascending catecholamine pathways in the mesencephalon pre vented the development of the acute spasm (Fig. 3) .
There was no paralysis in any of the animals post SAH. The normal and solvent-injected animals were noticeably drowsy during the 2 days following the blood injection. In contrast, the lesioned an imals seemed unaffected by the SAH. The animals treated neonatally with 6-0HDA had a 92% decrease in the NA content of the frontal lobes, a 48% increase in the NA content in the pons-medulla, and a 33% decrease in the NA con tent in the hypothalamus as compared with solvent injected animals (Table 2) . However, the NA con tent of the paraventricular or supraoptic nuclei was not influenced by the neonatal 6-0HDA treatment. In the animals treated in the neonatal stage with 6-OHDA and subsequently with lesioning of the as cending catecholamine pathways in the mesenceph- alon, there was a further decrease of 14% in the NA content of the frontal lobes and of 42% in the NA levels in the hypothalamus as compared with the neonatally 6-0HDA-treated animals. In the pons medulla there was a 23% increase in the NA con tent (Table 2) .
DISCUSSION
The present study shows that systemic injection in the rat of 6-0HDA neonatally prevents the de velopment of late spasm after cisternal blood injec tion while the acute spasm is of the same magnitude as that seen in normal or solvent-ir\iected animals. Lesioning of the ascending catecholamine fibers in the mesencephalon in animals treated neonatally with 6-0HDA prevents the development of the acute spasm.
Owing to lack of a blood-brain barrier in rats during the first days after birth (Sachs, 1973; Kostr zewa and Harper, 1975) , systemic injection of 6-OHDA produces marked alterations in the projec tion patterns of the central catecholamine systems (Malmfors and Thoenen, 1971) . Histochemical and biochemical investigations in animals treated neo natally with 6-0HDA in dosages comparable with those given in this study have shown that both as cending and descending fibers from the catechol amine nuclei in the pons and medulla oblongata un dergo degeneration (Jonsson et a!., 1974; Levitt and Moore, 1980) . Liew and Laverty (1975) and Ver steeg et al. (1977) found a decrease in the NA con tent of the frontal cortex of 82 and 97%, respec tively, from control levels in 2-to 3-month-old rats treated neonatally with 6-0HDA. Our findings of a 92% decrease are in accordance with these figures. The NA levels in the hypothalamus were found by Jonsson and Sachs (1976) in 2-month-old animals to be reduced by 40%. The decrease in the hypotha lamic NA content seen in the present material is of a similar magnitude. Versteeg et al. (1977) found that 3 months after 6-0HDA treatment, the NA content in the peri ventricular and arcuate nuclei and the median eminence were decreased to one half of normal. No changes were found in the para ventricular and supraoptic nuclei. Jonsson et al. (1974) and Schmidt and Bhatnagar (1979) found an increase in the NA content of 73 and 70%, respec tively, in the pons-medulla oblongata. In the present material, the increase was 48%. The in crease might be due to a local collateral sprouting secondary to an impaired axonal regeneration (Sachs and Jonsson, 1975) .
In newborn rats, high doses of 6-0HDA (100 mg/kg daily during the first 3 days after birth) in jected subcutaneously also produce a total sym pathectomy secondary to destruction of the sympa thetic ganglia (Angeletti and Levi-Montalcini, 1970; Angeletti, 1971) . Accordingly, no sympathetic nerve terminals were seen in the irides 3-4 months after the injection in our study.
What is the reason for the lack of late spasm in the neonatally 6-0HDA-treated animals, and why do they develop acute spasm? In a previous com munication, we have demonstrated that destruction of the ascending catecholamine pathways from the AI and A2 nuclei in the medulla oblongata to the hypothalamus prevents the occurrence of both the acute and the late spasm phase following an SAH (Svendgaard et a!., 1985b). Also, it was shown that selective lesion of the median eminence prevents the development of both spasm phases (Svendgaard et a!., 1986) . We have interpreted the absence of late spasm in the neonatally 6-0HDA-treated an imals as being due to degeneration of the ascending catecholamine pathways from the medulla oblon gata to the median eminence. However, it cannot be excluded that the absence of the late spasm phase is due partially to the lack of sympathetic in nervation in the neonatally 6-0HDA-treated an imals, since there is both clinical (Kodama et a!., 1980) and experimental (Svendgaard et aI., 1985a) evidence that the sympathetic system contributes to the development of spasm in the late phase.
The occurrence of acute spasm in neonatally treated animals combined with its absence in an imals that had an additional lesion of the ascending catecholamine pathways in the mesencephalon re- affirms that a central catecholamine mechanism un derlies the acute spasm. It also suggests that there could be a different susceptibility to neonatal 6-OHDA treatment of the ascending catecholamine projection in the brainstem responsible for the acute versus the late spasm. Ascending projections from A2 are involved in both the acute and the late spasm, while projections from AI are involved only in the development of late spasm (Svendgaard et ai., 1987) . Different cellular subgroups within A2 might be responsible for the acute and the late spasm and have a disparate sensitivity to 6-0HDA. There could also be a different rate of regeneration of the central catecholamine neurons, responsible for the two spasm phases. The catecholamine fibers in the brainstem are known to regenerate after le sioning (Svendgaard et aI., 1975) . The increasing NA content in the hypothalamus with age in neona tally 6-0HDA-treated animals (Liew and Laverty, 1975) favors the regeneration theory. The occur rence of acute spasm in the neonatally 6-0HDA treated animals that lack a sympathetic system re confirms the assumption that the sympathetic system is of no importance to the acute spasm (Svendgaard et aI., 1985a) . The paraventricular and the supraoptic nuclei, which are heavily innervated from A I and A2, have been demonstrated by Versteeg et al. (1977) to have a normal NA content in neonatally 6-0HDA treated animals. Our data are in agreement with these findings. A presumed normal function of these nuclei suggests that they could be involved in the development of acute spasm. The nuclei could be involved via their release of vasopressin and oxytocin in the median eminence.
The increase in MABP and the bradycardia re corded immediately after the SAH in the neonatally 6-0HDA-treated animals with subsequent mesen cephalic lesions probably represent an exaggerated Cushing response. The adrenal medulla, which is known not to be damaged by neonatal 6-0HDA treatment (Mueller, 1971) , has been shown by Reis et al. (1979) to play a role in the Cushing response.
In conclusion, the occurrence of acute but not late spasm in animals treated neonatally with 6-OHDA reinforces the theory of different pathways involved in the two phases.
